Prot# NLG-0405: A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreatic Cancer Vaccine in Subjects with Surgically Resected Pancreatic Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date6/30/10 → 6/30/17

Funding

  • NewLink Genetics Corporation (NLG-0405)